Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12B6K | ISIN: US9286611077 | Ticker-Symbol:
NASDAQ
22.04.24
15:39 Uhr
0,596 US-Dollar
-0,028
-4,48 %
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
VOLITIONRX LIMITED Chart 1 Jahr
5-Tage-Chart
VOLITIONRX LIMITED 5-Tage-Chart

Aktuelle News zur VOLITIONRX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.03.VolitionRx Limited (VNRX) Q4 2023 Earnings Call Transcript6
27.03.Earnings call: VolitionRx reports robust revenue growth, eyes breakeven6
26.03.VolitionRX reports FY results9
25.03.VOLITIONRX LTD - 10-K, Annual Report6
25.03.VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update79Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., March 25, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE...
► Artikel lesen
22.03.Earnings Outlook For VolitionRX5
20.03.VolitionRx Names Andrew Retter Chief Medical Officer3
19.03.VolitionRx Limited: Volition appoints Dr Andrew Retter as Chief Medical Officer251HENDERSON, Nev., March 19, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed Dr Andrew Retter as its Chief Medical...
► Artikel lesen
19.03.VOLITIONRX LTD - 8-K, Current Report2
08.02.VolitionRx - Snaring sepsis, with early NETs detection395VolitionRx continues to make headway in growing a body of clinical evidence to build Nu.Q® NETs as a potential breakthrough tool in sepsis. These efforts, coupled with its CE mark in Europe, are a strong...
► Artikel lesen
02.01.VolitionRx stock soars after company discloses $13M in milestone payments41
02.01.VOLITIONRX LTD - 8-K, Current Report21
14.12.23VolitionRx director buys stock worth $6,00025
05.12.23VOLITIONRX LTD - 8-K, Current Report18
27.11.23VolitionRx director acquires stock worth $14,20014
16.11.23VolitionRx Limited (VNRX) Q3 2023 Earnings Call Transcript9
15.11.23VolitionRX reports Q3 results11
14.11.23VOLITIONRX LTD - 8-K, Current Report4
14.11.23VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update216Conference call to discuss financial and operational results scheduled for Wednesday, November 15, at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., Nov. 14, 2023 /PRNewswire/ -- VolitionRx Limited...
► Artikel lesen
13.11.23Earnings Preview: VolitionRX7
Seite:  Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1